Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Angiogenesis Inhibitors”

206 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 206 results

Not applicableLooking for participantsNCT05718492
What this trial is testing

The Application of HAIC in Advanced HCC Previously Treated With ICIs and Antiangiogenic Agents

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 100
Early research (Phase 1)Study completedNCT00052559
What this trial is testing

Bevacizumab, Fluorouracil, and External-Beam Radiation Therapy in Treating Patients With Stage II or Stage III Rectal Cancer

Who this might be right for
Adenocarcinoma of the RectumStage II Rectal CancerStage III Rectal Cancer
National Cancer Institute (NCI) 32
Not applicableStudy completedNCT03156868
What this trial is testing

Analysis of Soluble Mediators,Cytokines and FACs as Prognostic Factors in Advanced Non-squamous Lung Carcinoma

Who this might be right for
Non-small Cell Lung Cancer
Spanish Lung Cancer Group 153
Testing effectiveness (Phase 2)UnknownNCT00622726
What this trial is testing

Bevacizumab Eliminates the Angiogenic Threat for Retinopathy of Prematurity

Who this might be right for
Retinopathy of Prematurity
The University of Texas Health Science Center, Houston 150
Testing effectiveness (Phase 2)Ended earlyNCT01215578
What this trial is testing

Predictive Biomarkers of Response to Sunitinib in the Treatment of Poorly-differentiated NEURO-Endocrine Tumors

Who this might be right for
Neuroendocrine TumorsPancreatic NeoplasmsAdvanced Disease+1 more
Assistance Publique - Hôpitaux de Paris 33
Testing effectiveness (Phase 2)Study completedNCT02484716
What this trial is testing

Efficacy of a Timolol Nasal Spray as a Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT) - (TEMPO)

Who this might be right for
Telangiectasia, Hereditary HemorrhagicOsler Rendu Disease
Hospices Civils de Lyon 58
Not applicableStudy completedNCT01132833
What this trial is testing

Biomarkers Related to Thrombosis in Patients With Newly Diagnosed Multiple Myeloma Receiving Chemotherapy

Who this might be right for
Multiple MyelomaPlasma Cell NeoplasmThromboembolism
UNC Lineberger Comprehensive Cancer Center 18
Not applicableNot Yet RecruitingNCT06682247
What this trial is testing

A Real-world Study of Chidamide in Combination with PD-1/PD-L1 Antibodies and Anti-angiogenic Agents in Advanced MSS Colorectal Cancer

Who this might be right for
Colorectal Cancer Metastatic
Feng Wang 200
Early research (Phase 1)Study completedNCT00822848
What this trial is testing

Sorafenib, Epirubicin, Ifosfamide, and Radiation Therapy Followed By Surgery in Treating Patients With High-Risk Stage II or Stage III Soft Tissue Sarcoma

Who this might be right for
Sarcoma
OHSU Knight Cancer Institute 18
Early research (Phase 1)Study completedNCT01514123
What this trial is testing

Study of VGX-100 Administered Alone and Co-administered With Bevacizumab in Adult Subjects With Advanced Solid Tumors

Who this might be right for
NeoplasmsCancer
Circadian Technologies Ltd. 43
Early research (Phase 1)UnknownNCT00639925
What this trial is testing

Antiangiogenic Peptide Vaccine Therapy With Gemcitabine in Treating Patient With Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Fukushima Medical University 5
Early research (Phase 1)Ended earlyNCT01548924
What this trial is testing

Determination of Dose of Antiangiogenic Multitargeted DOVITINIB (TKI258) Plus Paclitaxel in Patients With Solid Tumors

Who this might be right for
Solid Tumors
Centro Nacional de Investigaciones Oncologicas CARLOS III 13
Testing effectiveness (Phase 2)Study completedNCT00655785
What this trial is testing

Antiangiogenic Peptide Vaccine Therapy With Gemcitabine in Treating Patient With Pancreatic Cancer (Phase1/2)

Who this might be right for
Pancreatic Cancer
Fukushima Medical University 17
Not applicableUnknownNCT03583242
What this trial is testing

Multimodal Image Study of Retinal Inflammation Markers After Corticoid and Antiangiogenic Treatment in Pacients With Diabetic Macular Edema

Who this might be right for
Diabetic Macular Edema
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 80
Early research (Phase 1)Study completedNCT00622622
What this trial is testing

Gemcitabine With Antiangiogenic Peptide Vaccine Therapy in Patients With Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Wakayama Medical University 21
Not applicableNot Yet RecruitingNCT06858956
What this trial is testing

Real-World Study of Chidamide Combined With PD-(L)1 Inhibitors and Anti-Angiogenic Therapy for Advanced MSS-Type Colorectal Cancer

Who this might be right for
Colorectal Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 200
Early research (Phase 1)Study completedNCT02042781
What this trial is testing

Study of the Safety and Tolerability of IV Infused PG545 in Patients With Advanced Solid Tumours

Who this might be right for
Advanced Solid Tumours
Zucero Pty Ltd 23
Testing effectiveness (Phase 2)UnknownNCT05842018
What this trial is testing

Toripalimab in Combination With Chemotherapy and Antiangiogenic Agents in Patients With Non-Small Cell Lung Cancer After Failure of Immunotherapy (PD-1/L1 Inhibitors)

Who this might be right for
Non Small Cell Lung Cancer Recurrent
Tianjin Medical University Cancer Institute and Hospital 30
Testing effectiveness (Phase 2)Study completedNCT00843440
What this trial is testing

Efficacy and Safety of Bevacizumab for the Treatment Hemorrhagic Hereditary Telangiectasia (HHT) Associated With Severe Hepatic Vascular Malformations. Phase II Study

Who this might be right for
Hemorrhagic Hereditary Telangiectasia
Hospices Civils de Lyon 25
Large-scale testing (Phase 3)Ended earlyNCT01009593
What this trial is testing

Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular Carcinoma Non-resectableHepatocellular Carcinoma RecurrentCarcinoma, Hepatocellular+10 more
Abbott 1,035
Next Page